GDNF and Parkinson disease: While the use of either exogenous BDNF or GDNF has been proposed as a therapeutic alternative for treating PD by restoring neurotrophic support in the brain [76,77,78], it is important to note that these neurotrophic factors have a low diffusion rate and therefore are limited in their ability to cross the BBB [79].